Gina M. Fadayel
Procter & Gamble (United States)(US)
Publications by Year
Research Areas
Neurotransmitter Receptor Influence on Behavior, Cardiac electrophysiology and arrhythmias, Dermatology and Skin Diseases, Atrial Fibrillation Management and Outcomes, Neuroscience and Neuropharmacology Research
Most-Cited Works
- → Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies.(1993)256 cited
- → 5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine(1992)162 cited
- → The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat(1995)118 cited
- → Regional effects of MK-801 on dopamine release: effects of competitive NMDA or 5-HT2A receptor blockade.(1996)118 cited
- → Aging-Associated Changes in the Adult Human Skin Microbiome and the Host Factors that Affect Skin Microbiome Composition(2021)94 cited
- → Epidermal changes associated with symptomatic resolution of dandruff: biomarkers of scalp health(2010)72 cited
- → Discovery and in vitro/in vivo studies of tetrazole derivatives as Kv1.5 blockers(2006)52 cited
- → Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist(1997)48 cited
- → The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine(1992)44 cited
- → Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats.(1992)44 cited